Site menu

Search by ticker code:
Generic filters


Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

HY21: BWX (ASX:BWX) share price goes nuts on Chemist Warehouse deal

The BWX Ltd (ASX: BWX) share price is going nuts after announcing its HY21 result and a new deal with Chemist Warehouse.

BWX is a business that sells a variety of natural beauty products.

HY21 result numbers

BWX reported that its net revenue rose by 0.6% to $84.5 million. In constant currency terms that growth was 3.4%.

Underlying EBITDA (EBITDA explained) went up by 1.4% to $11.7 million, with reported EBITDA growing by 53.5% to $17.5 million.

BWX said that its marketing investment as a percentage of net revenue continues to grow year on year at 14.2% in line with its target range and reflects a commitment to educating consumers on the benefits of natural beauty products.

Further efficiency gains supported the delivery of a total operating expenses ratio of 42.4%, down 0.2% on the prior corresponding period.

Statutory net profit after tax (NPAT) jumped by 133.1% to $9.9 million.

BWX balance sheet and dividend

BWX announced a fully franked interim dividend of 1 cent per share. It said that strong cash conversion helped grow its net cash position by 171% to $77.7 million.

Growth initiatives

The natural business announced a number of different updates. I’ll start with the smaller ones.

It announced a Woolworths Group Ltd (ASX: WOW) retail partnership which will see Sukin launched in 930 stores.

BWX revealed the first 10 direct to consumer websites will be launched across five countries via The Hut Group.

The company was pleased to say it has achieved distribution gains in global retailers including Walmart (Canada) and natural supermarkets as well as the relaunch of Mineral Fusion in Wholefood Markets.

BWX’s big news was a 5-year equity-linked alliance with Chemist Warehouse Group to fuel growth of Sukin, Andalou Naturals and Mineral Fusion in Australia and international markets. It will a ‘platinum supplier’ with the entire range available online as well as an increased store presence in Australia, New Zealand and Ireland.

The initial tranche of shares to Chemist Warehouse represents 0.6% of BWX at a share price of $3.97. This can increase to 2.4% based on performance targets. This deal is expected to deliver positive profit / earnings per share (EPS)

Summary thoughts

BWX said that it’s on track to meet its full year FY21 guidance of revenue and EBITDA growth of 10%. The new deal is very promising because Chemist Warehouse is such a large retailer in Australia. It could help it become a much larger business. Scale has a lot of benefits for manufacturing companies. The improving profit margins are important and the new manufacturing facility will be really useful for this.

I think BWX could be one to watch, but it’s likely to be a bumpy journey over the years. Natural beauty demand is not a steady path of growth.

Before you consider BWX, I suggest getting a free Rask account and accessing our full stock reports. Click this link to join for free and access our analyst reports.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.
Skip to content